A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors
Clinical trial NCT03196297 · COMPLETED
Trial details
- NCT number
- NCT03196297
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2018-06-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.